Design, synthesis, and biological evaluation of novel substituted thiourea derivatives as potential anticancer agents for NSCLC by blocking K-Ras protein-effectors interactions
Mutation of the proto-oncogene K-Ras is one of the most common molecular mechanisms in non-small cell lung cancer. Many drugs for treating lung cancer have been developed, however, due to clinical observed K-Ras mutations, corresponding chemotherapy and targeted therapy for such mutation are not eff...
Main Authors: | Yuan Zhang, Xin Meng, Haikang Tang, Minghui Cheng, Fujun Yang, Wenqing Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14756366.2019.1702653 |
Similar Items
-
K-RAS and N-RAS mutations in testicular germ cell tumors
by: Bekir Muhammet Hacioglu, et al.
Published: (2017-05-01) -
Discovery of small molecules blocking oncogenic K-Ras activity
by: Kovar, Sarah E.
Published: (2018) -
Concurrent mutation in exons 1 and 2 of the K-ras oncogene in colorectal cancer
by: Fiorella Guadagni, et al.
Published: (2012-01-01) -
Clinical relevance of the K-ras oncogene in colorectal cancer: Experience in a Mexican population
by: F. Cabrera-Mendoza, et al.
Published: (2014-07-01) -
K-RAS mutation profile in colorectal carcinoma patients in Sanglah Hospital Denpasar, Bali-Indonesia
by: Luh Putu Iin Indrayani M, et al.
Published: (2017-08-01)